Watch some of our top soundbites from a number of discussions with experts who presented at PAS 2025. Thank you for visiting the Contemporary Pediatrics website, and for following along with our ...

Mona Shahriari, MD, discusses how RAD 2025 can equip providers with tools to improve atopic dermatitis outcomes. As dermatologic science continues to evolve, the Revolutionizing Atopic Dermatitis (RAD ...

In this article, we recap our top stories, expert interviews, and Q+A discussions from the 2025 Pediatric Academic Societies meeting. The 2025 Pediatric Academic Societies meeting, held in Honolulu, ...

Nirsevimab significantly reduces RSV-related hospitalisations, ICU admissions, and LRTIs in infants, but doesn’t shorten hospital stays, according to a recent study. A systematic review and ...

Another month has come and gone, and with it, several FDA approvals and regulatory updates related to the ever-evolving landscape of pediatric health care. In our April monthly recap, we list our top ...

During the 2025 Pediatric Academic Societies Meeting, Lea Widdice, MD, presented on "Know Your Role in OTC STI Testing." Widdice is director of the Adolescent Medicine Fellowship and associate ...

A recent study conducted in the United Kingdom has revealed a significant association between maternal anemia in early pregnancy and the increased risk of congenital heart disease (CHD) in offspring.

Poll: Can you diagnose this 13-year-old female with altered mental status?

FDA announces measures to phase out petroleum-based food dyes ...

FDA announces measures to phase out petroleum-based food dyes ...

A PAS 2025 study by Mazar and Westmoreland shows Zika virus can eliminate both local and distant tumors in neuroblastoma mouse models. At the 2025 Pediatric Academic Societies Meeting, Joseph Mazar, ...

On April 30, 2025, the FDA approved nipocalimab-aahu (Imaavy; Johnson & Johnson), a human FcRn-blocking monoclonal antibody, for the treatment of generalized myasthenia gravis (gMG) in adult and ...